CG
BIOR

Cutler Group’s Biora Therapeutics, Inc. Common Stock BIOR Stock Holding History

Cutler Group’s Portfolio BIOR Stock Details BIOR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-2
Closed -$71 – 4453
2023
Q1 		$0 Sell
2
-41
-95% -$1.39K ﹤0.01% 5113
2022
Q4 		$1K Sell
43
-10
-19% -$729 ﹤0.01% 4264
2022
Q3 		$6K Buy
53
+28
+112% +$5.04K ﹤0.01% 3590
2022
Q2 		$4K Sell
25
-249
-91% -$52.5K ﹤0.01% 3967
2022
Q1 		$79K Buy
274
+77
+39% +$29.2K ﹤0.01% 1885
2021
Q4 		$102K Buy
+197
New +$141K ﹤0.01% 1839

Other funds holding BIOR

ACM
Athyrium Capital Management New York $8.69M AUM 34.58% 1-Year Est. Return
AFM
Anson Funds Management Dallas, Texas $2.29B AUM 370.24% 1-Year Est. Return
SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SSA
Schonfeld Strategic Advisors New York $14.2B AUM 37.17% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Creative Planning
Creative Planning Overland Park, Kansas $147B AUM 18.73% 1-Year Est. Return

Cutler Group's BIOR Position: Q2 2023 in Review

Cutler Group sold out of Biora Therapeutics, Inc. Common Stock (BIOR) in Q2 2023, closing a stake of 2 shares — an estimated $71 sold.

Cutler Group first reported a position in BIOR in Q4 2021 and held it in 6 quarters. The position peaked at $102K in Q4 2021. 30 funds tracked by Wall St. Rank hold BIOR as of Q2 2023.

  • Cutler Group reported no remaining Biora Therapeutics, Inc. Common Stock position as of Q2 2023 after selling out during the quarter.
  • Cutler Group sold 2 Biora Therapeutics, Inc. Common Stock shares in Q2 2023, an estimated $71.
  • Cutler Group first reported a position in Biora Therapeutics, Inc. Common Stock in Q4 2021 and held it in 6 quarters.
  • Cutler Group's Biora Therapeutics, Inc. Common Stock position peaked at $102K in Q4 2021.
  • 30 funds tracked by Wall St. Rank held Biora Therapeutics, Inc. Common Stock as of Q2 2023.

Based on Cutler Group's 13F filing for Q2 2023, filed 18 Jul 2023.